Legacy Financial Strategies, LLC Abbott Laboratories Transaction History

Legacy Financial Strategies, LLC

$448 Million
Q3 2024

A detailed history of Legacy Financial Strategies, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Legacy Financial Strategies, LLC holds 25,220 shares of ABT stock, worth $2.88 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

25,220

Previous 25,322 0.4%

Holding current value

$2.88 Million

Previous $2.63 Million 9.27%

% of portfolio

0.64%

Previous 0.64%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$100.07 - $118.13 $10,207 - $12,049	-102 Reduced 0.4%	25,220 $2.88 Million
Q2 2024 Jul 10, 2024	BUY	$100.73 - $112.44 $274,388 - $306,286	2,724 Added 12.05%	25,322 $2.63 Million
Q1 2024 Apr 10, 2024	BUY	$109.52 - $120.96 $130,000 - $143,579	1,187 Added 5.54%	22,598 $2.57 Million
Q4 2023 Feb 01, 2024	BUY	$90.19 - $110.4 $6,223 - $7,617	69 Added 0.32%	21,411 $2.36 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $35,919 - $43,097	-376 Reduced 1.73%	21,342 $2.07 Million
Q2 2023 Jul 28, 2023	BUY	$100.78 - $112.29 $216,777 - $241,535	2,151 Added 10.99%	21,718 $2.37 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $155,169 - $182,644	1,602 Added 8.92%	19,567 $1.98 Million
Q4 2022 Feb 15, 2023	BUY	$95.06 - $111.52 $121,201 - $142,188	1,275 Added 7.64%	17,965 $1.97 Million
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $169,910 - $196,724	1,756 Added 11.76%	16,690 $1.62 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $149,430 - $180,613	1,464 Added 10.87%	14,934 $1.62 Million
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $68,069 - $83,006	597 Added 4.64%	13,470 $1.59 Million
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $37,547 - $45,974	325 Added 2.59%	12,873 $1.81 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $79,912 - $88,406	685 Added 5.77%	12,548 $1.48 Million
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $98,173 - $115,563	928 Added 8.49%	11,863 $1.38 Million
Q1 2021 May 07, 2021	BUY	$108.84 - $128.23 $32,107 - $37,827	295 Added 2.77%	10,935 $1.31 Million
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $7,770 - $8,467	74 Added 0.7%	10,640 $1.17 Million
Q3 2020 Nov 03, 2020	BUY	$91.64 - $111.29 $33,540 - $40,732	366 Added 3.59%	10,566 $1.15 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $781,013 - $999,600	10,200 New	10,200 $933,000
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $633,400 - $738,735	-8,691 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $37,745 - $45,634	-570 Reduced 6.15%	8,691 $695,000
Q4 2018 Feb 15, 2019	BUY	$65.56 - $74.27 $17,766 - $20,127	271 Added 3.01%	9,261 $670,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $76,985 - $92,873	1,266 Added 16.39%	8,990 $625,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $43,638 - $48,163	758 Added 10.88%	7,724 $471,000
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $97,684 - $110,444	1,736 Added 33.19%	6,966 $417,000
Q4 2017 May 14, 2018	BUY	$53.68 - $57.47 $280,746 - $300,568	5,230	5,230 $298,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Strategies, LLC with notifications on news.

Account

Legacy Financial Strategies, LLC Abbott Laboratories Transaction History